Axitinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Axitinib
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Axitinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 6 USDMF, 5 EU WC, 4 NDC API, 20 Listed Suppliers, $ API Reference Price

26 API Suppliers
6 USDMF
5 EU WC
4 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

39 Drugs in Development

39 Drugs in Development

INTERMEDIATES

19 Intermediates Suppliers

19 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 6 FDA Orange Book, 22 Europe, 2 Canada, 4 Australia, 2 South Africa, 4 Listed Dossiers

40 FDF Dossiers
6 FDA Orange Book
22 Europe
2 Canada
4 Australia
2 South Africa
4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 DKSH, 3 Faran Shimi Pharmaceutical, 9 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 5 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Vasa Pharmachem

1 SPI Pharma
2 DKSH
3 Faran Shimi Pharmaceutical
9 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
5 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
17 Kerry
9 Microlex e.U
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
10 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 19 Direct Compression, 14 Disintegrants & Superdisintegrants, 11 Co-Processed Excipients, 10 Granulation, 10 Lubricants & Glidants, 10 Thickeners and Stabilizers, 7 Coating Systems & Additives, 4 Film Formers & Plasticizers, 4 Controlled & Modified Release, 3 Taste Masking, 2 Coloring Agents, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 Emulsifying Agents, 1 Parenteral

40 Fillers, Diluents & Binders
19 Direct Compression
14 Disintegrants & Superdisintegrants
11 Co-Processed Excipients
10 Granulation
10 Lubricants & Glidants
10 Thickeners and Stabilizers
7 Coating Systems & Additives
4 Film Formers & Plasticizers
4 Controlled & Modified Release
3 Taste Masking
2 Coloring Agents
2 Rheology Modifiers
2 Chewable & Orodispersible Aids
1 Emulsifying Agents
1 Parenteral

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 75 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
75 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 15 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
15 Finished Drug Prices
10 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

16 US Patents, 8 Health Canada Patents

16 US Patents
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 453,498 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Pfizer Canada ULC

filter Patent Reset all filters

8 All

01 42383630

02 42682859

filter Product Reset all filters

8 All

01 4AXITINIB

02 4Axitinib

filter Dosage Reset all filters

8 All

01 4TABLET

02 4Tablet

filter Exp Date Reset all filters

8 All

01 42020-06-30

02 42028-03-25

Product Main Page

01

Pfizer Canada ULC

Axitinib

Antibody Engineering

Not Confirmed

Pfizer Canada ULC

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Brand Name : INLYTA

Patent Number : 2383630

Filing Date : 2000-06-30

Strength per Unit : 1 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada ULC

Axitinib

Antibody Engineering

Not Confirmed

Pfizer Canada ULC

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Brand Name : INLYTA

Patent Number : 2383630

Filing Date : 2000-06-30

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada ULC

Axitinib

Antibody Engineering

Not Confirmed

Pfizer Canada ULC

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Brand Name : INLYTA

Patent Number : 2682859

Filing Date : 2008-03-25

Strength per Unit : 1 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada ULC

Axitinib

Antibody Engineering

Not Confirmed

Pfizer Canada ULC

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Brand Name : INLYTA

Patent Number : 2682859

Filing Date : 2008-03-25

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Portfolio PDF

Product Web Link

Digital Content

05

Pfizer Canada ULC

Axitinib

Antibody Engineering

Not Confirmed

Pfizer Canada ULC

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Brand Name : INLYTA

Patent Number : 2383630

Filing Date : 2000-06-30

Strength per Unit : 3 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

06

Pfizer Canada ULC

Axitinib

Antibody Engineering

Not Confirmed

Pfizer Canada ULC

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Brand Name : INLYTA

Patent Number : 2682859

Filing Date : 2008-03-25

Strength per Unit : 3 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Portfolio PDF

Product Web Link

Digital Content

07

Pfizer Canada ULC

Axitinib

Antibody Engineering

Not Confirmed

Pfizer Canada ULC

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Brand Name : INLYTA

Patent Number : 2682859

Filing Date : 2008-03-25

Strength per Unit : 7 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Portfolio PDF

Product Web Link

Digital Content

08

Pfizer Canada ULC

Axitinib

Antibody Engineering

Not Confirmed

Pfizer Canada ULC

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Brand Name : INLYTA

Patent Number : 2383630

Filing Date : 2000-06-30

Strength per Unit : 7 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?